Category
»
Primary study
Registry of Trials»ISRCTN registry
Year
»
2023
INTERVENTION: Randomisation will be at the child level, stratified by site (University of Manchester/University of Reading) and by the child’s main form of communication (spoken/sign/spoken+sign) as assessed by parent report. Randomisation will be conducted by an independent randomization service provider. Children and their parents will be randomly allocated to the intervention (PACT‐DS programme) group or to the waiting list control group. Families allocated to the PACT‐DS group will be trained to deliver PACT‐DS to their child at home in daily (5 Xweek) sessions of about 20‐25 minutes over 30 weeks of teaching. All materials and resources needed to deliver the programme will be provided. Families in the waiting control group will be offered general training on supporting language development for children with Down syndrome. This will involve three sessions, delivered to parents as a group, over the delivery phase. In addition, on completion of the trial, they will have the option of receiving PACT‐DS or an evidence‐based reading intervention for children with Down syndrome (RLI). CONDITION: Supporting early language development in children with Down syndrome ; Genetic Diseases ; Down syndrome INCLUSION CRITERIA: 1. Child has a diagnosis of Down syndrome 2. Child aged 3‐6 years at the start of the study 3. Family home postcode is within 40 miles of the University of Manchester/University of Reading 4. Parents can read and speak English 5. Child has a minimum expressive vocabulary of 10 (English) words/signs (measured via parent‐completed Reading Communicative Development Inventory) 6. Child has a minimum cognitive level of 18 months (as assessed by the research team using the Mullen Scale of Early Learning) PRIMARY OUTCOME: ; The feasibility of a future definitive trial of the PACT‐DS programme, assessed using:; 1. The number of participants interested in taking part, consented, completed screening, eligible, and randomised [within 18 months of start date].; 2. Adherence to and acceptability of the PACT‐DS intervention via measures of attendance at training, number of intervention sessions completed, number of participants withdrawing from intervention, and intervention fidelity as well as records of email and telephone support provided to families, surveys and qualitative interviews [within 33 months of start date]; 3. The acceptability and experience of the trial process to participants, including randomisation and completion of outcome measures [within 33 months of the start date].; 4. The optimal primary outcome measure in a future trial, determined by assessing the performance of selected candidate primary outcome measures with respect to the level of acceptability to participants (completion rates, perceived burden) and reliability [within 33 months of start date].; 5. Estimated sample size for a future trial by measuring participant withdrawal, data completeness at follow‐up (participant attrition) and group differences and 95% confidence intervals for child language measures at immediate and delayed follow‐up [within 33 months of start date]; 6. The potential benefits and costs in a future trial including benefits for child and parent outcomes and costs of intervention including intervention materials and resources and staff time for training and support (in line with recent cost guidance from the Education Endowment Foundation) [within 33 months of start date].; ; Progression to definitive trial will be informed by the results of three main progression criteria:; Recruitment: at least 50% of the proposed sample (n = 28‐30) recruited to (i.e. take up an offered place in) feasibility study = Green; 40‐49% = Amber; below 40% = Red.; Intervention adherence: will be based on the experimental group delivering the programme; i.e. 50%+ of the intervention group complete =>17 weeks of the programme (the average completion rate in Burgoyne et al., 2018) = Green; 40‐49% = Amber; below 40% = Red.; Retention will be based on the proportion of the recruited sample that completes delayed post‐testing (i.e. children with quantitative data at delayed post‐test); i.e. 80%+ = Green; 50‐79% = Amber; <50% = Red.; SECONDARY OUTCOME: ; The outcome measures that will be evaluated within this feasibility study are listed below. The following measures are all collected at baseline (prior to randomisation) and at immediate post‐test (immediately following the 30‐week intervention phase) and follow‐up post‐test (6 months after the immediate post‐test) with all participants (in both groups) with the exception of the child emergent literacy measure (assessed at 6‐month follow‐up only):; ; Child Language:; 1. Child vocabulary, assessed using the parent‐completed Reading Communicative Development Inventory; 2. Child expressive and receptive vocabulary, assessed using the Expressive and Receptive One Word Picture Vocabulary Tests; 3. Child expressive information and grammar, assessed using the Action Picture Test; 4. Child Narrative Skills, assessed using a story retell task; 5. Child intervention vocabulary knowledge, assessed using a researcher‐developed task; 6. Parent‐child interaction, providing measures of child language and parent measures (e.g. responsiveness, use of language boosting strategies), assessed using video recordings of parents and children sharing books and playing together; ; Child Emergent Literacy (assessed only at 6‐month follow‐up):; 7. Child emergent literacy, assessed using the York Assessment of Reading for Comprehension (assessed at 6‐month follow‐up only); ; Home Learning Environment:; 8. Home Learning Environment, assessed using a Home Learning Environment questionnaire; ; Child Executive Functioning:; 9. Child executive functioning, assessed using the Behaviour Rating Inventory of Executive Functioning – Preschool; ; Parent Measures:; 10. Parent Knowledge, Skills, and Confidence in relation to language development, as assessed through a questionnaire based on the Theoretical Domains Framework; 11. Parent anxiety and depression, as measured by the Hospital Anxiety and Depression Scale (HADS); 12. Parental quality of life as assessed by the Adult Carer Quality of Life Questionnaire (AC‐QoL);
Epistemonikos ID: 5b5f8e70cf5005a6acdaac7f2fa6da85d5f3ad16
First added on: Aug 26, 2024